Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
出版年份 2010 全文链接
标题
Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 103, Issue 5, Pages 629-641
出版商
Springer Nature
发表日期
2010-07-28
DOI
10.1038/sj.bjc.6605814
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting
- (2010) D. Santini et al. CURRENT CANCER DRUG TARGETS
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials
- (2009) M. Gnant CURRENT CANCER DRUG TARGETS
- Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF
- (2009) Luigi Dolcetti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Myeloid-derived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development
- (2009) Verena Greifenberg et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Role of macrophages in tumour progression
- (2009) K.S. Siveen et al. IMMUNOLOGY LETTERS
- Zoledronic acid, an aminobisphosphonate, modulates differentiation and maturation of human dendritic cells
- (2009) Yu-Jen Chen et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Regulatory T cells: how do they suppress immune responses?
- (2009) S. Sakaguchi et al. INTERNATIONAL IMMUNOLOGY
- Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model
- (2009) Penelope D. Ottewell et al. INTERNATIONAL JOURNAL OF CANCER
- Chorionic gonadotropin alleviates thioglycollate-induced peritonitis by affecting macrophage function
- (2009) Hui Wan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer
- (2009) Kishan J. Pandya et al. LUNG CANCER
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Zoledronic Acid Is Effective against Experimental Malignant Pleural Effusion
- (2008) Georgios T. Stathopoulos et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow--a long-term follow-up
- (2008) I. J. Diel et al. ANNALS OF ONCOLOGY
- Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages
- (2008) Panagiotis Tsagozis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Macrophage-Derived SPARC Bridges Tumor Cell-Extracellular Matrix Interactions toward Metastasis
- (2008) Sabina Sangaletti et al. CANCER RESEARCH
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages
- (2008) Paola Allavena et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance
- (2008) Paola Allavena et al. IMMUNOLOGICAL REVIEWS
- Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics
- (2008) Naoki Umemura et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma
- (2008) N. R. Miselis et al. MOLECULAR CANCER THERAPEUTICS
- Nitric oxide, apoptosis and macrophage polarization during tumor progression
- (2008) Andreas Weigert et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Macrophage polarization in tumour progression
- (2008) Antonio Sica et al. SEMINARS IN CANCER BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started